ProPhase Labs, Inc. (PRPH)
OTCMKTS · Delayed Price · Currency is USD
0.0500
-0.0100 (-16.67%)
At close: Jul 30, 2026
ProPhase Labs Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -23.88 | -38.13 | -102.89 | -33.16 | 18.46 | 6.27 |
Depreciation & Amortization | 4.31 | 4.83 | 6.19 | 6.05 | 4.72 | 3.23 |
Stock-Based Compensation | 1.76 | 1.89 | 3.64 | 3.54 | 3.99 | 3.18 |
Other Adjustments | 4.45 | 7.91 | 13.01 | 1.32 | 5.72 | 8.31 |
Change in Receivables | 0.88 | 0.74 | 4.74 | -0.62 | -4.5 | -38.2 |
Changes in Inventories | 0.32 | 0.31 | 1.36 | 0.17 | 0.7 | -1.75 |
Changes in Accounts Payable | 1.23 | -0.72 | 5.07 | 2.86 | -1.12 | 2.45 |
Changes in Accrued Expenses | -0.02 | -0.11 | -0.16 | -0.77 | -0.89 | 1.89 |
Changes in Income Taxes Payable | -0.67 | -1.71 | -1.29 | -0.91 | 2.88 | - |
Changes in Unearned Revenue | -0.54 | -0.34 | -1 | -0.08 | 0.62 | 2.61 |
Changes in Other Operating Activities | 2.99 | 1.64 | 6.17 | -7.38 | -2.03 | -1.62 |
Operating Cash Flow | -5.71 | -8.34 | -17.54 | -11.89 | 28.55 | -13.62 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | - | - | -0.91 | -2.08 | -3.92 | -4.23 |
Sale of Property, Plant & Equipment | 0.08 | 0.12 | 0.23 | 0.05 | 0.45 | - |
Purchases of Investments | - | - | - | -3.82 | -6.78 | -21.53 |
Proceeds from Sale of Investments | - | - | 3.37 | 7.99 | 8.17 | 15.86 |
Cash Acquisitions | - | - | - | -2.9 | - | -9.07 |
Other Investing Activities | - | - | - | 0.48 | - | -0.7 |
Investing Cash Flow | 0.08 | 0.92 | 2.42 | -1.37 | -2.08 | -19.67 |
Long-Term Debt Issued | 0.29 | 7.57 | 9.86 | 7.6 | - | - |
Long-Term Debt Repaid | -2.77 | -4.26 | -4.25 | - | -7.04 | -0.05 |
Net Long-Term Debt Issued (Repaid) | -2.48 | 3.31 | 5.61 | 7.6 | -7.04 | -0.05 |
Issuance of Common Stock | 0.32 | 3.56 | 7.59 | 1.2 | - | 40.64 |
Repurchase of Common Stock | - | - | - | -5.97 | -9.63 | -0.92 |
Net Common Stock Issued (Repurchased) | 0.32 | 3.56 | 7.59 | -4.77 | -9.63 | 39.72 |
Common Dividends Paid | - | - | - | - | -9.35 | -4.55 |
Financing Cash Flow | 5.58 | 6.84 | 14.19 | 5.76 | -26.02 | 35.13 |
Net Cash Flow | -0.06 | -0.59 | -0.93 | -7.5 | 0.45 | 1.84 |
Free Cash Flow | -5.71 | -8.34 | -18.44 | -13.97 | 24.63 | -17.85 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -139.87% | -192.04% | -272.44% | -39.94% | 20.08% | -22.58% |
Free Cash Flow Per Share | -0.53 | -0.98 | -9.22 | -8.12 | 13.21 | -9.70 |
Levered Free Cash Flow | -18.74 | -7.52 | -32.32 | -11.32 | 12.38 | 8.81 |
Unlevered Free Cash Flow | -10.21 | -14.14 | -29.76 | -17.66 | 19.97 | 14.17 |